Scleritis and Systemic Disease Association in a Community-Based Referral Practice

American Journal of Ophthalmology

Volumn 148, Issue 6, 2009, Pages 946-950

  Raiji, Veena Rao ^a   Palestine, Alan Gary ^a   Parver, David Leland ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL PRACTICE; COMMUNITY CARE; CORNEA DISEASE; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; EYE SURGERY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT REFERRAL; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCHOOL CHILD; SCLERITIS; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; SYSTEMIC VASCULITIS; TREATMENT RESPONSE; UVEITIS; VISION; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CHILD; COMMUNITY HEALTH SERVICES; FEMALE; HERPES ZOSTER; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SARCOIDOSIS; SCLERITIS; YOUNG ADULT;

EID: 70449632281     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.07.021     Document Type: Article

References (26)

1. Sainz de la Maza M., Foster C.S., and Jabbur N. Scleritis associated with systemic vasculitic diseases. Ophthalmology 102 (1995) 687-692
2. Akpek E.K., Thorne J.E., Qazi F.A., Do D.V., and Jabs D. Evaluation of patients with scleritis for systemic disease. Ophthalmology 111 (2004) 501-506
3. Okhravi N., Odufuwa B., McCluskey P., and Lightman S. Scleritis. Surv Ophthalmol 50 (2005) 351-363
4. Jabs D.A., Mudun A., Dunn J.P., and Marsh M. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 130 (2000) 469-476
5. Watson P.G., and Hayreh S.S. Scleritis and Episcleritis. Br J Ophthalmol 60 (1976) 163-191
6. Akpek E.K., Uy H.S., Christen W., Gurdal C., and Foster C.S. Severity of episcleritis and systemic disease association. Ophthalmology 106 (1999) 729-731
7. McCluskey P.J., Watson P.G., Lightman S., Haybittle J., Restori M., and Branley M. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106 (1999) 2380-2386
8. Smith J.R., Mackensen F., and Rosenbaum J.T. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 3 (2007) 219-226
9. Lin P., Bhullar S.S., Tessler H.H., and Goldstein D.A. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol 145 (2008) 463-471
10. Hoang L.T., Lim L.L., Vaillant B., Choi D., and Rosenbaum J.T. Anti-neutrophil cytoplasmic antibody-associated active scleritis. Arch Ophthalmol 126 (2008) 651-655
11. Sen H.N., Suhler E.B., Al-Khatib S.Q., Djalilan A.R., Nussenblatt R.B., and Buggage R.R. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology 110 (2003) 1750-1755
12. Thorne J.E., Jabs D.A., Qazi F.A., Nguyen Q.D., Kempen J.H., and Dunn J.P. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112 (2005) 1472-1477
13. Mohan N., Edwards E.T., Cupps T.R., et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 31 (2004) 1955-1958
14. Simms R., Kipgen D., Dahill S., Marshall D., and Rodger R.S. ANCA-associated renal vasculitis following anti-tumor necrosis factor therapy. Am J Kidney Dis 51 (2008) e11-e14
15. Guillevin L., and Mouthon L. Tumor necrosis factor-alpha blockade and the risk of vasculitis. J Rheumatol 31 (2004) 1885-1887
16. Sobrin L., Christen W., and Foster C.S. Mycophenolate mofetil after methotrexate failure of intolerance in the treatment of scleritis and uveitis. Ophthalmology 115 (2008) 1416-1421
17. Jabs D.A., Rosenbaum J.T., Foster C.S., et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory diseases: recommendations from an expert panel. Am J Ophthalmol 130 (2000) 492-513
18. Larkin G., and Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology 106 (1999) 370-374
19. Baltatzis S., Tufail F., Yu E.N., Vredeveld C.M., and Foster C.S. Mycophenolate mofetil as immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 110 (2003) 1061-1065
20. Thorne J.E., Hernandez M.I., Rencic A., and Nousari H.C. Severe scleritis and urticarial lesions. Am J Ophthalmol 134 (2002) 932-934
21. Zurdel J., Aboalchamat B., Zierhut M., Stubiger N.B., and Engelmann K. Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid [in German]. Klin Monatsbl Augenheilkd 218 (2001) 222-228
22. Kilmartin D.J., Forrester J.V., and Dick A.D. Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet 352 (1998) 35-36
23. Sainz de la Maza M., Foster C.S., Jabbur N.S., and Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 120 (2002) 15-19
24. Fraunfelder F.W., and Fraunfelder F.T. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol 135 (2003) 219-222
25. Fraunfelder F.W., and Fraunfelder F.T. Bisphosphonates and ocular inflammation. N Engl J Med 348 (2003) 1187-1188
26. French D.D., and Margo C. Post-marketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 28 (2008) 889-893